A panel of experts recommends the FDA withdraw Avastin as a breast cancer fighting drug.
Avastin went on the market in 2008 after a trial showed it delayed breast cancer symptoms, but a follow-up study couldn't replicate the results.
The FDA, however, doesn't always follow the panel's advice.
Viewers with disabilities can get assistance accessing this station's FCC Public Inspection File by contacting the station with the information listed below. Questions or concerns relating to the accessibility of the FCC's online public file system should be directed to the FCC at 888-225-5322, 888-835-5322 (TTY), or email@example.com.